Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Perlman

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Drug and Alcohol Dependence|July 29, 2011
Can intranasal drug use reduce HCV infection among injecting drug users?Don C Des Jarlais, Holly Hagan, Kamyar Arasteh, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses: A "Big Events" PerspectiveSamuel R Friedman, Ashly E Jordan, David C Perlman, et al.
Drug and Alcohol Dependence|April 21, 2015
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013Ashly E Jordan, Don C Des Jarlais, Kamyar Arasteh, et al.
Journal of Health Communication|August 28, 2016
Feasibility of a Computer-Based Intervention Addressing Barriers to HIV Testing Among Young Patients Who Decline Tests at TriageIan David Aronson, Charles M Cleland, David C Perlman, et al.
The Journal of Infectious Diseases|September 3, 2020
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment ProgramAshly E Jordan, Charles M Cleland, Bruce R Schackman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 3, 2020
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluationAshly E Jordan, David C Perlman, Charles M Cleland, et al.
Substance Use & Misuse|March 8, 2021
Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York CityBrandon Muncan, Ashly E Jordan, David C Perlman, et al.
American Journal of Public Health|October 3, 2009
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programsDon C Des Jarlais, Kamyar Arasteh, Holly Hagan, et al.
The Journal of Infectious Diseases|September 3, 2020
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York CityAshly E Jordan, Charles M Cleland, Katarzyna Wyka, et al.
Plos One|July 5, 2013
HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV InfectionDon C Des Jarlais, Kamyar Arasteh, Courtney McKnight, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Drug and Alcohol Dependence|July 29, 2011
Can intranasal drug use reduce HCV infection among injecting drug users?Don C Des Jarlais, Holly Hagan, Kamyar Arasteh, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses: A "Big Events" PerspectiveSamuel R Friedman, Ashly E Jordan, David C Perlman, et al.
Drug and Alcohol Dependence|April 21, 2015
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013Ashly E Jordan, Don C Des Jarlais, Kamyar Arasteh, et al.
Journal of Health Communication|August 28, 2016
Feasibility of a Computer-Based Intervention Addressing Barriers to HIV Testing Among Young Patients Who Decline Tests at TriageIan David Aronson, Charles M Cleland, David C Perlman, et al.
The Journal of Infectious Diseases|September 3, 2020
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment ProgramAshly E Jordan, Charles M Cleland, Bruce R Schackman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 3, 2020
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluationAshly E Jordan, David C Perlman, Charles M Cleland, et al.
Substance Use & Misuse|March 8, 2021
Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York CityBrandon Muncan, Ashly E Jordan, David C Perlman, et al.
American Journal of Public Health|October 3, 2009
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programsDon C Des Jarlais, Kamyar Arasteh, Holly Hagan, et al.
The Journal of Infectious Diseases|September 3, 2020
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York CityAshly E Jordan, Charles M Cleland, Katarzyna Wyka, et al.
Plos One|July 5, 2013
HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV InfectionDon C Des Jarlais, Kamyar Arasteh, Courtney McKnight, et al.
Pageof 12